Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10458)
All Articles published online
|
Publishing Process of This Article
|
Apr 28, 2015 (publication date) through Jul 31, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tijera FHDL, Servín-Caamaño AI, Serralde-Zúñiga AE, Cruz-Herrera J, Pérez-Torres E, Abdo-Francis JM, Salas-Gordillo F, Pérez-Hernández JL. Metadoxine improves the three- and six-month survival rates in patients with severe alcoholic hepatitis. World J Gastroenterol 2015; 21(16): 4975-4985 [PMID: 25945012 DOI: 10.3748/wjg.v21.i16.4975] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v21/i16/4975.htm |
| Number | Citing Articles |
| 1 |
Kris Bennett, Doyo G. Enki, Mark Thursz, Matthew E. Cramp, Ashwin D. Dhanda. Systematic review with meta‐analysis: high mortality in patients with non‐severe alcoholic hepatitis. Alimentary Pharmacology & Therapeutics 2019; 50(3): 249 doi: 10.1111/apt.15376
|
| 2 |
Lukas Van Melkebeke, Hannelie Korf, Emmanuel A. Tsochatzis, Schalk van der Merwe, Frederik Nevens, Jef Verbeek. Treatment of severe alcoholic hepatitis: A systematic review. Current Opinion in Pharmacology 2021; 60: 91 doi: 10.1016/j.coph.2021.06.011
|
| 3 |
Mette M. Berger, Alan Shenkin, Oguzhan Sıtkı Dizdar, Karin Amrein, Marc Augsburger, Hans-Konrad Biesalski, Stephan C. Bischoff, Michael P. Casaer, Kursat Gundogan, Hanna-Liis Lepp, Angélique M.E. de Man, Giovanna Muscogiuri, Magdalena Pietka, Loris Pironi, Serge Rezzi, Anna Schweinlin, Cristina Cuerda. ESPEN practical short micronutrient guideline. Clinical Nutrition 2024; 43(3): 825 doi: 10.1016/j.clnu.2024.01.030
|
| 4 |
E. T. Goh, M. Y. Morgan. Review article: pharmacotherapy for alcohol dependence – the why, the what and the wherefore. Alimentary Pharmacology & Therapeutics 2017; 45(7): 865 doi: 10.1111/apt.13965
|
| 5 |
Mette M. Berger, Alan Shenkin, Anna Schweinlin, Karin Amrein, Marc Augsburger, Hans-Konrad Biesalski, Stephan C. Bischoff, Michael P. Casaer, Kursat Gundogan, Hanna-Liis Lepp, Angélique M.E. de Man, Giovanna Muscogiuri, Magdalena Pietka, Loris Pironi, Serge Rezzi, Cristina Cuerda. ESPEN micronutrient guideline. Clinical Nutrition 2022; 41(6): 1357 doi: 10.1016/j.clnu.2022.02.015
|
| 6 |
Lindsey C. Shipley, Page D. Axley, Ashwani K. Singal. Liver Fibrosis: A Clinical Update. EMJ Hepatology 2019; : 105 doi: 10.33590/emjhepatol/10313576
|
| 7 |
Gene Y. Im. Acute Alcoholic Hepatitis. Clinics in Liver Disease 2019; 23(1): 81 doi: 10.1016/j.cld.2018.09.005
|
| 8 |
J.A. Velarde-Ruiz Velasco, M.F. Higuera-de la Tijera, G.E. Castro-Narro, F. Zamarripa-Dorsey, J.M. Abdo-Francis, I. Aiza Haddad, J.M. Aldana Ledesma, M.V. Bielsa-Fernández, E. Cerda-Reyes, L.E. Cisneros-Garza, R. Contreras-Omaña, A. Reyes-Dorantes, N.J. Fernández-Pérez, E.S. García-Jiménez, M.E. Icaza-Chávez, D. Kershenobich-Stalnikowitz, M.A. Lira-Pedrín, R. Moreno-Alcántar, J.L. Pérez-Hernández, M.V. Ramos-Gómez, M.T. Rizo-Robles, S. Solana-Sentíes, A. Torre-Delgadillo. The Mexican consensus on alcoholic hepatitis. Revista de Gastroenterología de México (English Edition) 2020; 85(3): 332 doi: 10.1016/j.rgmxen.2020.04.004
|
| 9 |
Jiazhen Zheng, Ziyi Li, Hengyi Xu. Intestinal Microbiotas and Alcoholic Hepatitis: Pathogenesis and Therapeutic Value. International Journal of Molecular Sciences 2023; 24(19): 14809 doi: 10.3390/ijms241914809
|
| 10 |
Tejasav S Sehrawat, Mengfei Liu, Vijay H Shah. The knowns and unknowns of treatment for alcoholic hepatitis. The Lancet Gastroenterology & Hepatology 2020; 5(5): 494 doi: 10.1016/S2468-1253(19)30326-7
|
| 11 |
Chen Liu, Tianying Cai, Yonglang Cheng, Junjie Bai, Mo Li, Boyuan Gu, Meizhou Huang, Wenguang Fu. Postbiotics Prepared Using Lactobacillus reuteri Ameliorates Ethanol‐Induced Liver Injury by Regulating the FXR/SHP/SREBP‐1c Axis. Molecular Nutrition & Food Research 2024; 68(14) doi: 10.1002/mnfr.202300927
|
| 12 |
Yange Liu, Juan Wang, Lanzhou Li, Wenji Hu, Yidi Qu, Yipei Ding, Lina Meng, Lirong Teng, Di Wang. Hepatoprotective Effects of Antrodia cinnamomea: The Modulation of Oxidative Stress Signaling in a Mouse Model of Alcohol-Induced Acute Liver Injury. Oxidative Medicine and Cellular Longevity 2017; 2017: 1 doi: 10.1155/2017/7841823
|
| 13 |
Sally Condon, Loretta L. Jophlin. Past, Present, and Future Therapies for Alcohol-associated Hepatitis. Clinical Therapeutics 2023; 45(12): 1171 doi: 10.1016/j.clinthera.2023.10.013
|
| 14 |
Tom Ryu, Kyurae Kim, Sung Eun Choi, Katherine Po Sin Chung, Won-Il Jeong. New insights in the pathogenesis of alcohol-related liver disease: The metabolic, immunologic, and neurologic pathways☆. Liver Research 2023; 7(1): 1 doi: 10.1016/j.livres.2022.09.004
|
| 15 |
Sandeep Singh Sidhu, Omesh Goyal, Harsh Kishore, Simran Sidhu. New paradigms in management of alcoholic hepatitis: a review. Hepatology International 2017; 11(3): 255 doi: 10.1007/s12072-017-9790-5
|
| 16 |
Deepa Patel, Christopher S. Holaway, Sonia Thomas, Harish Parihar, Zhiqian Wu, Skye Bickett, Vicky V. Mody. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. Side Effects of Drugs Annual 2016; 38: 355 doi: 10.1016/bs.seda.2016.08.025
|
| 17 |
Giacomo Germani, Francesca D’Arcangelo, Marco Grasso, Patrizia Burra. Advances and Controversies in Acute Alcohol-Related Hepatitis: From Medical Therapy to Liver Transplantation. Life 2023; 13(9): 1802 doi: 10.3390/life13091802
|
| 18 |
Akshay Patel, Andras Perl. Redox Control of Integrin-Mediated Hepatic Inflammation in Systemic Autoimmunity. Antioxidants & Redox Signaling 2022; 36(7-9): 367 doi: 10.1089/ars.2021.0068
|
| 19 |
Ayooluwatomiwa Deborah Adekunle, Adeyinka Adejumo, Ashwani K. Singal. Therapeutic targets in alcohol-associated liver disease: progress and challenges. Therapeutic Advances in Gastroenterology 2023; 16: 175628482311709 doi: 10.1177/17562848231170946
|
| 20 |
Sukhpreet Singh, Natalia A Osna, Kusum K Kharbanda. Treatment options for alcoholic and non-alcoholic fatty liver disease: A review. World Journal of Gastroenterology 2017; 23(36): 6549-6570 doi: 10.3748/wjg.v23.i36.6549
|
| 21 |
J.A. Velarde-Ruiz Velasco, M.F. Higuera-de la Tijera, G.E. Castro-Narro, F. Zamarripa-Dorsey, J.M. Abdo-Francis, I. Aiza Haddad, J.M. Aldana Ledesma, M.V. Bielsa-Fernández, E. Cerda-Reyes, L.E. Cisneros-Garza, R. Contreras-Omaña, A. Reyes-Dorantes, N.J. Fernández-Pérez, E.S. García-Jiménez, M.E. Icaza-Chávez, D. Kershenobich-Stalnikowitz, M.A. Lira-Pedrín, R. Moreno-Alcántar, J.L. Pérez-Hernández, M.V. Ramos-Gómez, M.T. Rizo-Robles, S. Solana-Sentíes, A. Torre-Delgadillo. Consenso Mexicano de hepatitis alcohólica. Revista de Gastroenterología de México 2020; 85(3): 332 doi: 10.1016/j.rgmx.2020.04.002
|
| 22 |
Ali Wakil, Mumtaz Niazi, Mohamad A. Meybodi, Nikolaos T. Pyrsopoulos. Emerging Pharmacotherapies in Alcohol-Associated Hepatitis. Journal of Clinical and Experimental Hepatology 2023; 13(1): 116 doi: 10.1016/j.jceh.2022.06.012
|
| 23 |
You Ming Li, Jian Gao Fan. Guidelines of prevention and treatment for alcoholic liver disease (2018, China). Journal of Digestive Diseases 2019; 20(4): 174 doi: 10.1111/1751-2980.12687
|
| 24 |
David Tornai, Gyongyi Szabo. Emerging medical therapies for severe alcoholic hepatitis. Clinical and Molecular Hepatology 2020; 26(4): 686 doi: 10.3350/cmh.2020.0145
|
| 25 |
Ashwani K. Singal, Vijay H. Shah. Zakim and Boyer's Hepatology. 2018; : 351 doi: 10.1016/B978-0-323-37591-7.00024-0
|
| 26 |
Carolina L Haass-Koffler, Fatemeh Akhlaghi, Robert M Swift, Lorenzo Leggio. Altering ethanol pharmacokinetics to treat alcohol use disorder: Can you teach an old dog new tricks?. Journal of Psychopharmacology 2017; 31(7): 812 doi: 10.1177/0269881116684338
|
| 27 |
Shasha Cheng, Yi Kuang, Guodong Li, Jia Wu, Chung-Nga Ko, Wanhe Wang, Dik-Lung Ma, Min Ye, Chung-Hang Leung. Dehydroeburicoic Acid, a Dual Inhibitor against Oxidative Stress in Alcoholic Liver Disease. Pharmaceuticals 2022; 16(1): 14 doi: 10.3390/ph16010014
|
| 28 |
Wen-Jun Wang, Peng Xiao, Hong-Qin Xu, Jun-Qi Niu, Yan-Hang Gao. Growing burden of alcoholic liver disease in China: A review. World Journal of Gastroenterology 2019; 25(12): 1445-1456 doi: 10.3748/wjg.v25.i12.1445
|
| 29 |
Yu. V. Bykov, R. A. Bekker. Pleiotropic effects of Metadoxil in the treatment of acute and chronic alcohol intoxications. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY 2023; 57(3): 98 doi: 10.31363/2313-7053-2023-869
|
| 30 |
Karli R. LeFort, Wiramon Rungratanawanich, Byoung-Joon Song. Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction. Cellular and Molecular Life Sciences 2024; 81(1) doi: 10.1007/s00018-023-05061-7
|
| 31 |
Mark Thursz, Timothy R. Morgan. Treatment of Severe Alcoholic Hepatitis. Gastroenterology 2016; 150(8): 1823 doi: 10.1053/j.gastro.2016.02.074
|
| 32 |
Lindsey C. Shipley, Sudha Kodali, Ashwani K. Singal. Recent updates on alcoholic hepatitis. Digestive and Liver Disease 2019; 51(6): 761 doi: 10.1016/j.dld.2019.03.023
|
| 33 |
Pranav Penninti, Ayooluwatomiwa D. Adekunle, Ashwani K. Singal. Alcoholic Hepatitis. Medical Clinics of North America 2023; 107(3): 533 doi: 10.1016/j.mcna.2022.12.005
|
| 34 |
Puru Rattan, Vijay H. Shah. Review article: current and emerging therapies for acute alcohol‐associated hepatitis. Alimentary Pharmacology & Therapeutics 2022; 56(1): 28 doi: 10.1111/apt.16969
|
| 35 |
Elena Buzzetti, Maria Kalafateli, Douglas Thorburn, Brian R Davidson, Maja Thiele, Lise Lotte Gluud, Cinzia Del Giovane, Gro Askgaard, Aleksander Krag, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease). Cochrane Database of Systematic Reviews 2017; 2017(4) doi: 10.1002/14651858.CD011646.pub2
|
| 36 |
Szu-Yi Liu, I-Ting Tsai, Yin-Chou Hsu. Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives. International Journal of Molecular Sciences 2021; 22(10): 5170 doi: 10.3390/ijms22105170
|
| 37 |
M. Antonelli, F. A. Mancarella, A. Mirijello, C. Tarli, S. Mannucci, V. Maccauro, G. Di Sario, T. Dionisi, L. Sestito, A. Tosoni, G. Addolorato. Alcohol and Alcohol-related Diseases. 2023; : 383 doi: 10.1007/978-3-031-32483-3_22
|
| 38 |
Ramón Bataller, Joaquín Cabezas, Rocío Aller, Meritxell Ventura-Cots, Javier Abad, Agustín Albillos, José Altamirano, María Teresa Arias-Loste, Rafael Bañares, Juan Caballería, Llorenç Caballería, José Antonio Carrión, Moisés Diago, Conrado Fernández-Rodríguez, Rocío Gallego, Miren García-Cortes, Carmelo García-Monzón, Joan Genescà, Pere Ginés, Manuel Hernandez-Guerra, Francisco Jorquera, Anna Lligoña, Esther Molina, María Jesús Pareja, Ramón Planas, Santiago Tomé, Javier Salmerón, Manuel Romero-Gómez. Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH. Gastroenterología y Hepatología (English Edition) 2019; 42(10): 657 doi: 10.1016/j.gastre.2019.09.003
|
| 39 |
Eileen L. Yoon, Won Kim. Current and future treatment for alcoholic‐related liver diseases. Journal of Gastroenterology and Hepatology 2023; 38(8): 1218 doi: 10.1111/jgh.16257
|
| 40 |
Ashwani K. Singal, Sudha Kodali, Lee A. Vucovich, Victor Darley-Usmar, Thomas D. Schiano. Diagnosis and Treatment of Alcoholic Hepatitis: A Systematic Review. Alcoholism: Clinical and Experimental Research 2016; 40(7): 1390 doi: 10.1111/acer.13108
|
| 41 |
Phoenix Fung, Nikolaos Pyrsopoulos. Emerging concepts in alcoholic hepatitis. World Journal of Hepatology 2017; 9(12): 567-585 doi: 10.4254/wjh.v9.i12.567
|
| 42 |
Ma Ai Thanda Han, Nikolaos Pyrsopoulos. Emerging Therapies for Alcoholic Hepatitis. Clinics in Liver Disease 2021; 25(3): 603 doi: 10.1016/j.cld.2021.03.006
|
| 43 |
Yoonji Ha, Inju Jeong, Tae Hyun Kim. Alcohol-Related Liver Disease: An Overview on Pathophysiology, Diagnosis and Therapeutic Perspectives. Biomedicines 2022; 10(10): 2530 doi: 10.3390/biomedicines10102530
|
| 44 |
Antonio Mirijello, Luisa Sestito, Mariangela Antonelli, Antonio Gasbarrini, Giovanni Addolorato. Identification and management of acute alcohol intoxication. European Journal of Internal Medicine 2023; 108: 1 doi: 10.1016/j.ejim.2022.08.013
|
| 45 |
Wenjun Wang, Ying Xu, Chang Jiang, Yanhang Gao. Advances in the treatment of severe alcoholic hepatitis. Current Medical Research and Opinion 2019; 35(2): 261 doi: 10.1080/03007995.2018.1479247
|
| 46 |
Ramón Bataller, Joaquín Cabezas, Rocío Aller, Meritxell Ventura-Cots, Javier Abad, Agustín Albillos, José Altamirano, María Teresa Arias-Loste, Rafael Bañares, Juan Caballería, Llorenç Caballería, José Antonio Carrión, Moisés Diago, Conrado Fernández Rodríguez, Rocío Gallego, Miren García-Cortes, Carmelo García-Monzón, Joan Genescà, Pere Ginés, Manuel Hernandez-Guerra, Francisco Jorquera, Anna Lligoña, Esther Molina, María Jesús Pareja, Ramón Planas, Santiago Tomé, Javier Salmerón, Manuel Romero-Gómez. Enfermedad hepática por alcohol. Guías de práctica clínica. Documento de consenso auspiciado por la AEEH. Gastroenterología y Hepatología 2019; 42(10): 657 doi: 10.1016/j.gastrohep.2019.09.006
|
| 47 |
Taylor Lehner, Bin Gao, Bryan Mackowiak. Alcohol metabolism in alcohol use disorder: a potential therapeutic target. Alcohol and Alcoholism 2024; 59(1) doi: 10.1093/alcalc/agad077
|
| 48 |
James J. Connolly, Kohtaro Ooka, Joseph K. Lim. Future Pharmacotherapy for Non-alcoholic Steatohepatitis (NASH): Review of Phase 2 and 3 Trials. Journal of Clinical and Translational Hepatology 2018; 6(3): 1 doi: 10.14218/JCTH.2017.00056
|
| 49 |
Tomoo Yamazaki, Bernd Schnabl. Acute alcohol‐associated hepatitis: Latest findings in non‐invasive biomarkers and treatment. Liver International 2023; doi: 10.1111/liv.15608
|
| 50 |
Michael Pimienta, Christine Tien, Norah A. Terrault. Prospective clinical trials and novel therapies in the medical management of severe alcohol‐associated hepatitis. Clinical Liver Disease 2022; 20(6): 202 doi: 10.1002/cld.1265
|
| 51 |
Francisco Idalsoaga, Gustavo Ayares, Luis Antonio Díaz, Jorge Arnold, María Ayala-Valverde, David Hudson, Marco Arrese, Juan Pablo Arab. Current and emerging therapies for alcohol-associated hepatitis. Liver Research 2023; 7(1): 35 doi: 10.1016/j.livres.2023.03.002
|
| 52 |
Philipp Kasper, Sonja Lang, Hans‐Michael Steffen, Münevver Demir. Management of alcoholic hepatitis: A clinical perspective. Liver International 2023; 43(10): 2078 doi: 10.1111/liv.15701
|
| 53 |
Emma Avitabile, Jordi Gratacós-Ginès, Martina Pérez-Guasch, Ana Belén Rubio, Queralt Herms, Marta Cervera, Ruth Nadal, Marta Carol, Núria Fabrellas, Pol Bruguera, Ana Llorente, Lluisa Ortega, Anna Lligoña, Laura Nuño, Neus Freixa, María Teresa Pons, Alba Díaz, Ramon Bataller, Pere Ginès, Hugo López-Pelayo, Elisa Pose. LIVER FIBROSIS SCREENING INCREASES ALCOHOL ABSTINENCE. JHEP Reports 2024; : 101165 doi: 10.1016/j.jhepr.2024.101165
|
| 54 |
Yoon Mee Yang, Ye Eun Cho, Seonghwan Hwang. Crosstalk between Oxidative Stress and Inflammatory Liver Injury in the Pathogenesis of Alcoholic Liver Disease. International Journal of Molecular Sciences 2022; 23(2): 774 doi: 10.3390/ijms23020774
|
| 55 |
Wajahat Mehal, Uyen To. New approaches for fibrosis regression in alcoholic cirrhosis. Hepatology International 2016; 10(5): 773 doi: 10.1007/s12072-016-9752-3
|
| 56 |
Jordan E. Dimmel, Anuj Patel, Jeffery F. Clark, Vishakha S. Bhave, Essie Samuel, Vicky Mody. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. Side Effects of Drugs Annual 2019; 41: 387 doi: 10.1016/bs.seda.2019.09.003
|
| 57 |
Jordi Gratacós-Ginès, Pol Bruguera, Martina Pérez-Guasch, Ana López-Lazcano, Roger Borràs, Helena Hernández-Évole, Maria T. Pons-Cabrera, Anna Lligoña, Ramón Bataller, Pere Ginès, Hugo López-Pelayo, Elisa Pose. Medications for alcohol use disorder promote abstinence in alcohol-associated cirrhosis: Results from a systematic review and meta-analysis. Hepatology 2024; 79(2): 368 doi: 10.1097/HEP.0000000000000570
|
| 58 |
Paula María Bermúdez-Duarte, José Alfredo Rivera-Rojas. Effect of Metadoxine on Chronic Primary Hepatopathies in Canines: Number of Cases. Revista MVZ Córdoba 2023; 28(3): e3103 doi: 10.21897/rmvz.3103
|
| 59 |
Fangfang Duan, Chen Liu, Chunyan Chang, Shanshan Song, Hang Zhai, Jun Cheng, Song Yang. Granulocyte colony-stimulating factor plus pentoxifylline increases short-term survival in patients with severe alcoholic hepatitis: a network meta-analysis. The American Journal of Drug and Alcohol Abuse 2024; 50(2): 191 doi: 10.1080/00952990.2023.2266117
|
| 60 |
Eyad Gadour, Tamer Mohamed, Zeinab Hassan, Abdalla Hassan. Meta-Analysis and Systematic Review of Primary Renal Tubular Acidosis in Patients With Autoimmune Hepatitis and Alcoholic Hepatitis. Cureus 2021; doi: 10.7759/cureus.15287
|
| 61 |
David W. Crabb, Gene Y. Im, Gyongyi Szabo, Jessica L. Mellinger, Michael R. Lucey. Diagnosis and Treatment of Alcohol‐Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology 2020; 71(1): 306 doi: 10.1002/hep.30866
|
| 62 |
Fátima Higuera‐de‐la‐Tijera, Jorge Emilio Lira‐Vera, Oscar Morales‐Gutiérrez, Moisés Martínez‐Castillo, Zaira Medina‐Ávila, Alfredo Servín‐Caamaño, José Luis Pérez‐Hernández, Gabriela Gutiérrez‐Reyes. Alcoholic Liver Disease. Clinical Liver Disease 2022; 19(2): 63 doi: 10.1002/cld.1164
|